Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Biomarker Discovery Outsourcing Services Market

Biomarker Discovery Outsourcing Services Market Share

Report ID: GMI7722
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Biomarker Discovery Outsourcing Services Market Share

The biomarker outsourcing companies are actively operating in the market, leveraging their research capabilities and global presence. These industry leaders offer diverse services, including target identification, assay development, and clinical trial support, fostering a competitive landscape where innovation, expertise, and global reach are critical differentiators.

Biomarker Discovery Outsourcing Services Market Companies

The prominent market players operating in the biomarker discovery outsourcing services industry are as mentioned below:

Bio-Rad Laboratories, Inc.
Parexel International (MA) Corporation
Svar Life Science
Sino Biological, Inc
ICON plc.
Integrated DNA Technologies, Inc.
Almac Group Limited
REPROCELL Inc.
Frontage Labs
Biomcare ApS
Crown Bioscience
RayBiotech, Inc.
Excelra
Evotec

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global biomarker discovery outsourcing services industry size was valued USD 11.4 billion in 2023 and is expected to reach USD 33.7 billion by 2032, propelled by a rising need for personalized medicine, prompting a surge in R&D activities.

The surrogate endpoints segment is expected to reach USD 16.2 billion by 2032 as they play a pivotal role in predicting treatment efficacy and safety during drug development.

North America biomarker discovery outsourcing services industry is anticipated to record around 12.3% CAGR from 2024 to 2032 as it is the primary hub for innovative pharmaceutical and biotechnology research.

Bio-Rad Laboratories, Inc., Parexel International (MA) Corporation, Svar Life Science, Sino Biological, Inc, ICON plc., Integrated DNA Technologies, Inc., Almac Group Limited, REPROCELL Inc., Frontage Labs, Biomcare ApS, Crown Bioscience, RayBiotech, Inc., Excelra, and Evotec.